Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA.

Sitong MingMo KanLiu LiuZhuang Zhang Xiaoran LiuYaxin LiuZhen LiYanhong ZhangQihang PangJianan LinHui LiQing YangXin Sui Xiaobo Qu Na Li

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

SMY significantly improves cardiac function, relieves myocardial cell fibrosis and necrosis, resists cardiac hypertrophy, improves blood lipid metabolism and energy metabolism, regulates intestinal microbial disturbance, and protects the heart.

Keyphrases

left ventricular
single cell
heart failure
microbial community
diabetic rats
cell therapy
atrial fibrillation
drug induced
fatty acid
stem cells
mesenchymal stem cells
stress induced